Summit Speaker Series: Mingyi Chen, MD, PhD
09 September, 2015
The 2015 Nevada Cancer Control Summit brings together expert speakers from throughout Nevada and the nation to discuss the latest topics in cancer control. Our next installment in the Summit Speaker Series highlights Mingyi Chen, MD, PhD, presenting “Treatment and Advances in Lymphoma.”
Dr. Chen is an Associate Professor in the Department of Pathology and Laboratory Medicine at University of California, Davis, Medical Center and Associate Medical Director at Shriners Hospital of Northern California. Dr. Chen’s clinical interests include hematopathology – lymphoma, leukemia, flow cytometry, bone marrow transplant, and diagnostic molecular pathology. His research interests also include molecular pathogenesis of lymphoma and leukemia, tumor immunology and graft versus host disease, as well as viral infections and cancergenesis and cancer stem cells.
Join us as Dr. Mingyi Chen discusses treatment of lymphoma with an emphasis on details for cancer registry professionals on Day 1 of the 2015 Nevada Cancer Control Summit. Registration is just $125 for both days and includes continuing education credit. Get details and explore the entire agenda here.